Amelie Erben from Hyperganic Group joins Adam Penna on this episode of the AM Voices podcast to discuss the current state of bioprinting and employing the rules of nature to algorithms that shape the future of additive manufacturing. 

Amelie covers what can be leveraged from the advantages that voxels have with cells and functional tissues to the bioprinting process from design, materials, simulation, to final application. 

Amelie Erben studied Engineering at the Technical University of Munich (TUM) and Technical University of Deflt with a specialization towards Medical Engineering in her Master’s. As a PhD student in Bioprinting at TUM and the Center of Regenerative Medicine and Tissue Engineering, Munich, she improved the micro printing workflow towards clinically relevant scaffolds. Challenged by the limitations of CAD tools to generate organotypical print templates for bioprinting, she demonstrated the capabilities of Algorithmic Engineering together with Hyperganic Group GmbH, where she is now working in Business Development. 

Hyperganic radically redefines engineering to help improve the future of humanity. The company's software platform creates parts, structures and entire machines through computer algorithms and AI, and enables mass production in digital factories using industrial 3D printing.